Target intelligence / Profile preview

Ischemic myocardium (null)

Target: null
Molecular classification: Other (tissue/state, not a molecule/receptor/classical target)

Overview

Ischemic myocardium refers to heart muscle that is not receiving adequate blood flow and oxygen due to blocked or narrowed coronary arteries. This results in impaired heart function and may cause symptoms such as chest pain (angina), arrhythmias, or heart failure. If prolonged, ischemia causes irreversible myocardial cell death (infarction). The clinical management of myocardial ischemia focuses on rapidly restoring oxygen supply (through medications or surgical intervention), minimizing tissue damage, and preventing complications such as heart failure or arrhythmias.

Other names: Ischemic heart muscleIschemic cardiac tissueMyocardial ischemiaCardiac ischemia

Mechanism of action

Restoration of blood flow (reperfusion: PCI, CABG, thrombolysis); Reduction of cardiac workload (beta-blockers, nitrates); Prevention of clot expansion (antiplatelet, anticoagulant therapies); Cardioprotection (metabolic modulation, experimental approaches like ischemic preconditioning/reperfusion injury attenuation)

Biological functions

Oxygen transport (impaired in this state)Cellular metabolism (compromised due to lack of oxygen and nutrients)Contractility (reduced pumping function)Cellular survival and death (apoptosis, necrosis may occur)

Disease associations

Cardiovascular diseaseMyocardial infarction (heart attack)Heart failureArrhythmias

Safety considerations

Risk of irreversible tissue damage (infarction)Arrhythmias/sudden deathHeart failure progression

Interacting drugs

Thrombolytics (e.g., alteplase)

5 more in the full profile.

Biomarkers

Troponin (for myocardial injury)Creatine kinase-MB (CK-MB)Electrocardiogram changes (ST elevation/depression)Imaging findings (echocardiography, MRI perfusion defects)

Beyond the preview

Go deeper on Ischemic myocardium (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ischemic myocardium (null).

Explore the full profile